Since 1997, SL Pharma Labs has provided high value and high
quality contract services for parenteral, ophthalmic and topical
drug product development and commercialization, including
formulation development, analytical/microbiological development,
early phase clinical manufacturing, full ICH quality control
commercial release and stability testing of marketed products.
SL Pharma’s mission is to support clients in meeting their CMC
product development, clinical manufacturing of innovative drug
products, scale-up of generic drug products, technology transfer
and regulatory approval toward meeting their commercialization
timelines and regulatory requirements.
What differentiates SL Pharma Labs from other contract research
and development organizations?
» experienced scientists and leadership from industry that
understand the challenges of drug product development and
commercialization processes in today’s highly regulated market
» adaptive and customized approach to the unique needs of
every client, drug product and project
» reliable partner that is committed to meeting client budget and
» collaborative project design and completion from start to finish
» track record of consistent high quality and GMP-Compliance
SL Pharma Labs has a team of experienced pharmaceutical
and biotechnology industry leaders with deep knowledge and
commitment to outstanding service. The company’s strategy is to
maintain small, agile project teams that collaborate with clients
to assure that all projects are completed efficiently and meeting
all project scope requirements.
SL Pharma Labs has excellent partnerships and collaborations
with several CMOs for commercial manufacture. Based on pre-established and very successful project management systems, we
work very closely with the selected CMO in transferring the required
technology in a seamless fashion and provide them technical
support through all phases of commercial manufacture including
scale-up and manufacture of validation and commercial batches.
SL Pharma Labs is experienced in working with both large and
small molecule focused clients that range from large, multi-national through virtual start-up organizations, located within
US and overseas. The commonality across the client base from
innovator drug companies through generic organizations is a
desire for efficient collaborative support that is done on time and
on budget every time.
SL Pharma Labs is a fully GMP-Compliant organization and
is located in the First State Industrial Park campus which is
approximately 35 minutes from the Philadelphia International
Airport and 5 minutes from the I- 95 Newport exit in Delaware.
The facility houses ICH stability chambers, clean rooms Class
100,000 to Class 100 for sterile and topical product development/
clinical manufacturing, QA storage, QC release and stability
testing of marketed products and a wide variety and range of
state-of-the art equipment and instrumentation to handle a wide
range of simple to highly complex projects.
SL Pharma Labs can handle cytotoxic compounds and Controlled
Substances Schedules II through V.
The facility is FDA registered and cGMP compliant and has
maintained a clean record with the FDA since the establishment
of the company in 1997.
• Parenterals, Ophthalmics, and Topicals
SL Pharma Labs, Inc.
• CMC Development Of Generic and Innovative Drug Products
• Phase 1 & Phase 2 Clinical Manufacturing- Fill And Finish
• Small and Large Molecules
• Formulation Development
• Analytical Method Development Testing
• Microbiological Development and Testing
– Sterility/ Endotoxin/ Bioburden
– Antibiotics and Antimicrobials
– Filter Validation Studies
• ICH Compliant Stability Testing For API And Drug Product
• Quality Control Release Testing Of Marketed Products
• Tech Transfers
• CMC Consulting and Regulatory Documentation Preparation
1300 First State Boulevard, Suite C
Wilmington, DE 19804